Status:

COMPLETED

Pioglitazone and Serum Asymmetric Dimethylarginine (ADMA) in Patients With Diabetes

Lead Sponsor:

Medical University of South Carolina

Collaborating Sponsors:

Takeda Pharmaceuticals North America, Inc.

Conditions:

Diabetes

Eligibility:

All Genders

40-75 years

Phase:

PHASE4

Brief Summary

SPECIFIC AIMS 1. To determine whether pioglitazone will reduce levels of asymmetric dimethylarginine(ADMA) in patients with diabetes. 2. To determine whether nitric oxide(NOx) products are increased ...

Detailed Description

The primary purpose of this study is to determine whether treatment with pioglitazone can reduce serum levels of asymmetric dimethylarginine (ADMA) in patients with adult diabetes. Recent research has...

Eligibility Criteria

Inclusion

  • Adults age 40--75 years-of-age, non-pregnant
  • Informed consent
  • History of type 2 Diabetes Mellitus
  • Stable weight for the last 3 months (no change greater than +5% of body weight)
  • ADMA \> 0.50 µM/L (mean of non-diabetic reference group) (Devangelio 2007)
  • On stable medical therapy for at least 3 months
  • A working telephone

Exclusion

  • Any history of known coronary heart disease, including a history of congestive heart failure, myocardial infarction, coronary re-vascularization, or stroke
  • Pregnancy
  • Chronic kidney disease, serum creatinine \>2.0mg/dl, chronic liver disease, or uncontrolled hypertension (\>160/100).
  • Current participation in a formal weight loss program or planning to start such a program during the next 3 months
  • Collagen vascular disease, infection, or other inflammatory condition
  • Electrocardiogram (EKG) evidence of ischemia or infarction
  • Macular edema (swelling of the back of the eye), recent excessive weight gain (over 5% of weight in 30 days), elevated liver function tests \> 2.5 X the upper limit, or history of osteoporosis

Key Trial Info

Start Date :

October 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2010

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT00770367

Start Date

October 1 2008

End Date

June 1 2010

Last Update

August 31 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Family Medicine, MUSC

Charleston, South Carolina, United States, 29425

Pioglitazone and Serum Asymmetric Dimethylarginine (ADMA) in Patients With Diabetes | DecenTrialz